Deep Apple Therapeutics Raises $52M to Pioneer AI-Powered Drug Discovery

Deep Apple Therapeutics focuses on discovering novel therapeutics for high-value targets, utilizing ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries.

Source: deep apple

Company Name: Deep Apple Therapeutics
Location: San Francisco, CA
Sector: Biotechnology/Pharmaceuticals
Funding Details: Series A funding of $52M

Investors: The round was led by Apple Tree Partners
Purpose of Investment: Expansion of operations and advancement of development efforts

Leadership: Spiros Liras, Ph.D., Founding CEO
Product: An AI-driven discovery engine for novel small molecule therapeutics
About Company: Deep Apple Therapeutics focuses on discovering novel therapeutics for high-value targets, utilizing ensemble cryo-EM, deep learning, and molecular docking screens of ultra-large libraries. The company's approach expedites the process from target identification to lead optimization, primarily focusing on integral membrane proteins.

Pelotero Secures $3M in Seed Funding for AI-Powered Player Intelligence Platform

Pelotero is pioneering the integration of AI with sports coaching to create personalized training experiences.

Brenig Therapeutics Secures $65M in Series A Funding for Neurology Drug Development

Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform,

Monarch Tractor Secures $133M in Series C Funding for AI-Driven Agricultural Expansion

Monarch Tractor is pioneering the transformation of the agricultural industry by integrating AI and autonomous technology into its electric vehicle solutions, thus enhancing farm management and sustainability practices globally.

Read next